United States · FDA National Drug Code directory
EZETIMIBE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-628_1d93c66e-c5ea-de6f-e063-6294a90acfb8
- Product NDC
- 31722-628
- Form
- TABLET
- Composition / generic term
- EZETIMIBE
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220726
- Source listing expiry
- 20261231
Source-listed ingredients
- EZETIMIBE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (31722-628-01) · 31722-628-01
- 500 TABLET in 1 BOTTLE (31722-628-05) · 31722-628-05
- 1000 TABLET in 1 BOTTLE (31722-628-10) · 31722-628-10
- 30 TABLET in 1 BOTTLE (31722-628-30) · 31722-628-30
- 100 BLISTER PACK in 1 CARTON (31722-628-31) / 10 TABLET in 1 BLISTER PACK · 31722-628-31
- 100 BLISTER PACK in 1 CARTON (31722-628-34) / 10 TABLET in 1 BLISTER PACK · 31722-628-34
- 90 TABLET in 1 BOTTLE (31722-628-90) · 31722-628-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →